Abstract
The invention relates to uses and methods implementing a non-naturally occurring mutated arylsulfotransferase comprising (i) an amino acid substitution in at least one amino acid position selected among positions 6, 7, 8, 9, 11, 17, 20, 33, 62, 97, 138, 195, 236, 239, 244, 263, and combinations thereof, wherein the position is relative to the amino acids sequence of rat arylsulfotransferase IV SEQ ID NO: 1, and (ii) an amino acid sequence having at least 60% sequence identity with amino acids sequence SEQ ID NO: 1 for sulfating a substrate. The mutated arylsulfotransferase may have a sulfotransferase activity for converting adenosine 3',5'-bisphosphate (PAP) into 3'-phosphoadenosine-5'-phosphosulfate (PAPS) enhanced compared to the wild-type enzyme.
Application documents
1
202417032937-TRANSLATIOIN OF PRIOIRTY DOCUMENTS ETC. [25-04-2024(online)].pdf
25 Apr 2024
2
202417032937-STATEMENT OF UNDERTAKING (FORM 3) [25-04-2024(online)].pdf
25 Apr 2024
3
202417032937-Sequence Listing in txt [25-04-2024(online)].txt
25 Apr 2024
4
202417032937-Sequence Listing in PDF [25-04-2024(online)].pdf
25 Apr 2024
5
202417032937-REQUEST FOR EXAMINATION (FORM-18) [25-04-2024(online)].pdf
25 Apr 2024
6
202417032937-FORM 18 [25-04-2024(online)].pdf
25 Apr 2024
7
202417032937-FORM 1 [25-04-2024(online)].pdf
25 Apr 2024
8
202417032937-DRAWINGS [25-04-2024(online)].pdf
25 Apr 2024
9
202417032937-DECLARATION OF INVENTORSHIP (FORM 5) [25-04-2024(online)].pdf
25 Apr 2024
10
202417032937-COMPLETE SPECIFICATION [25-04-2024(online)].pdf
25 Apr 2024
11
202417032937-FORM-26 [24-07-2024(online)].pdf
24 Jul 2024
12
202417032937-FORM 3 [31-08-2024(online)].pdf
31 Aug 2024
13
202417032937-Proof of Right [02-11-2024(online)].pdf
02 Nov 2024